These days，Pharmaceutical bidding for drugs in Guangdong Province: August 4th，Five regulatory documents (hereinafter referred to as the Measures "of the" Interim Measures for the Drug Transaction of Guangdong Medical Institutions "jointly issued by the 9 departments of Guangdong Province (hereinafter referred to as the" Measures ") collective hanging network。"Measures" formulated in accordance with the requirements of the policy spirit and other policy spirit。Overall look，The most noticeable is the new introduction of the price comparison trading rules。The main approach is to export & ldquo; stable export to the international mainstream market medicine & rdquo; & ldquo; Imitation drugs that are evaluated by quality consistency & rdquo;。In view of the introduction of the introduction of price comparison transactions is innovative practice，"Measures" stipulates that the comparison price coefficient is implemented with dynamic management。It is reported，The above standardized documents will be implemented from September 2。

 

  In addition，Shenzhen GPO case pilot，Breaking the track of Circular 7，Start exploring the road。The aforementioned stake sports betting app"stake online sports bettingMeasures" clearly proposed，Except for the region of procurement and reform pilot by the country and provincial approval of the country and provincial，The province's public grass -roots medical and health institutions and public medical institutions at or above the county level、Drug transactions of fixed -point private medical institutions for medical insurance applicable to these measures。Industry foreseeable，The drug competition in Guangdong in the province will increase。

 

  Introduction to the price comparison rule

 

  From the content of the file，Introduction to the price comparison rule is the biggest highlight。Guangdong Province said in a dedicated policy interpretation document: & ldquo; some periodic patent drugs and other drug prices have virtual high，Introduction to the price comparison transaction can make the expired patented drugs still have a relatively high winning bid price during the transition period when the quality of domestic imitation drugs has not been generally improved，Do not directly fight the price without the advantage，can be restricted by the price comparison coefficient due to the winning price，It will not be higher than domestic high -quality generic drug prices。New rules recognize quality differences between the current period of expired patented drugs and domestic drugs，Applicable & lsquo; high -quality and high -quality & rsquo; principles，Based on the results of the big data analysis and calculation of bidding transactions in more than two years in Guangdong Province。& rdquo;

 

  This，Vice President of Federal Pharmaceutical Marketing Gao Hongxing told reporters: & ldquo; in the long run，Domestic high -quality generic drugs can compete face -to -face with expired patent medicine。& rdquo;，& ldquo; The new file divides the quality level of non -base medicine to divide finely，Take the third level as an example，At present, the export medicine needs to be obtained for relevant certification，Reach the export scale，This kind of variety is currently not in China，varieties that have not passed consistency evaluations in China，In stake online sports bettingthese stake online sports bettingthree years cycles，I think，This is favorable to expire patent drug species。& rdquo;

 

  From the perspective of the "Measures" spirit，The enthusiasm of the expired patented drug company can be mobilized by the price comparison coefficient method，Taking into account the interests of expired patented drug companies，Realize the price reduction of expired patent drugs，In terms of rules, it is more transparent，Can reduce unnecessary interest games and social transaction costs。On the other hand，Provide a fair competition environment for domestic drug manufacturers，Promoting competition。

 

  What needs attention is，File allows grass -roots medical institutions to use a certain percentage of non -base medicine。So，In the past, high -quality products have no advantage in the bid in the base medicine standard，often exit，Now these products can turn around to participate in non -base medicine bids，Will the winning bid price be raised。

 

   & ldquo; I think，If the kernel of the reform does not touch the internal medical system，There is no substantial reform within the hospital，It is difficult to cure roots now。Allows the grassroots to use a certain percentage of non -base medicine，Is in cooperation with graded diagnosis and treatment，But I think，Whether the medication catalog is enough or mainly depends on the service ability of grass -roots medical care，If the reform is not in place，It may also cause a lot of pressure on medical insurance funds，Patients may not be able to really get benefits，How to operate its marketing model at the grassroots level is also questionable。& rdquo; Industry expert Li Mengru said。

 

  Bidding changed & ldquo; Questy & rdquo;

 

  From the content of the Measures，Trading rules have a major modification。The reporter compared the two new and old documents and found it，According to the spirit of Cultural No. 7，This "Measures" combined the trading rules of the base medicine with non -base drugs into one，Reduce the workload，Improve efficiency。More importantly，Turn the past & ldquo; Moon month bidding & rdquo; to & ldquo; quarter bidding & rdquo;。Some experts said: & ldquo; stake online sports bettingYueyue stake online sports bettingbidding is too frequent，Purchasing volume cannot be fully concentrated，It is easier for enterprises to perform illegal operations such as siege，reflected the price with quantity，To promote competition、A purpose of reducing the siege。& rdquo;

 

  Gao Hongxing just participated in Hubei、Jiangxi's standard，His feeling is，Price linkage is a big potential。& ldquo; In fact, whether it is January、In the first quarter、One year，Nothing will increase the cost of the enterprise，Because the new rules will slowly form a new balance，The company is most concerned about the continuous adjustment of the policy，The market to form a new balance requires time。& rdquo;

 

  The reporter also noticed，The file has further improved the bargaining method。Increased & ldquo; based on the medical institution's own bargaining or entrusted bargaining & rdquo;，Improve the bargaining ability of medical institutions，Reduce the cost of bargaining。According to the transaction method，The procurement period of medical institutions must not exceed one year，This will limit the operation with a long period of reporting the previous medical institution。

 

  Li Meng believes: & ldquo; extend the bidding cycle，It may not affect the exclusive variety much，Fierce competitive varieties may be more powerful。And，No export medicine、Imitation drugs、The highest division or more varieties are not off -off for，There is no expired patented medicine or expired patent medicine in the same group without quotation，Export medicine、Imitation drugs are traded by bidding process for many varieties，The expired patent medicines that are exclusive varieties are not higher than their own quotation and the low value of the national lowest winning price.，Many companies still feel the pressure。& rdquo;

 

  Contrast Code 7，"Measures" for the first time clearing the classification of the drug category consistent with the No. 7: First, according to the bargaining variety、Negotiation varieties、Fixed -point production varieties、Bad varieties and categories purchased in accordance with the stake sports betting appcurrent Stake Sports Bettingregulations of the state are classified and purchased; the second is to implement dual -envelope review。Except for the above -mentioned category purchased varieties，The remaining basic medicines and non -base medicine medical insurance directory varieties are implemented with dual envelope evaluation methods，and add first imitation drugs and other evaluation indicators; the first imitation drugs rose from 10 points from the solicitation of the comments to 12 points in the transaction method。

 

  But there are also corporate people who think: & ldquo; This is not enough for the substantial support for the first imitation，Although the point value is increased，But the technical label requirements are not high，The first imitation medicine did not form sufficient market -oriented competition。& rdquo;